Cargando…

COVID-19 Infection and Vaccination and Its Relation to Amyloidosis: What Do We Know Currently?

Amyloidosis is a complex disorder characterized by deposited insoluble fibrillar proteins which misfold into β-pleated sheets. The pathogenesis of amyloidosis can vary but can be the result of immune dysregulation that occurs from sustained high inflammatory states, often known as AA amyloidosis. Mu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leung, Wing-Yin, Wu, Henry H. L., Floyd, Lauren, Ponnusamy, Arvind, Chinnadurai, Rajkumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383215/ https://www.ncbi.nlm.nih.gov/pubmed/37514955 http://dx.doi.org/10.3390/vaccines11071139

Ejemplares similares

Arrhythmic Burden in Cardiac Amyloidosis: What We Know and What We Do Not
por: Argirò, Alessia, et al.
Publicado: (2022)

Cardiac amyloidosis and surgery: What do we know about rare diseases?
por: Mestres, Carlos A., et al.
Publicado: (2021)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008)

Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023)

Bacterial Vaginosis: What Do We Currently Know?
por: Abou Chacra, Linda, et al.
Publicado: (2022)

Vaginal Aging—What We Know and What We Do Not Know
por: Szymański, Jacek K., et al.
Publicado: (2021)

Transmission of Ebola Viruses: What We Know and What We Do Not Know
por: Osterholm, Michael T., et al.
Publicado: (2015)

P-glycoprotein and cancer: what do we currently know?
por: Pilotto Heming, Carlos, et al.
Publicado: (2022)

Neurologic Complications With Vaccines: What We Know, What We Don't, and What We Should Do
por: Nath, Avindra
Publicado: (2023)

Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know
por: Arepally, Gowthami M., et al.
Publicado: (2021)

Multimorbidity: What do we know? What should we do?
por: Navickas, Rokas, et al.
Publicado: (2016)

Cerebrospinal fluid circulation: What do we know and how do we know it?
por: Khasawneh, Ahmad H, et al.
Publicado: (2018)

Metal wear particles: What we know, what we do not know, and why
por: Billi, Fabrizio, et al.
Publicado: (2009)

Mechanisms of atrial fibrillation in athletes: what we know and what we do not know
por: Guasch, E., et al.
Publicado: (2018)

Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?
por: Rai, Mahendra, et al.
Publicado: (2021)

Ticks and Tularemia: Do We Know What We Don't Know?
por: Zellner, Briana, et al.
Publicado: (2019)

COVID-19 vaccines and pregnancy: What do we know?
por: Cottin, Judith, et al.
Publicado: (2021)

Cardiac surgery and the coronavirus disease 2019 pandemic: What we know, what we do not know, and what we need to do
por: Bakaeen, Faisal G., et al.
Publicado: (2020)

Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?
por: Gershman, Boris, et al.
Publicado: (2015)

Current Status of Echinoderm Genome Analysis - What do we Know?
por: Kondo, Mariko, et al.
Publicado: (2012)

Immune response in COVID-19: What do we currently know?
por: Oliveira, Daniela S., et al.
Publicado: (2020)

What Do We Currently Know About Patellofemoral Osteochondritis Dissecans?
por: Bonaspetti, Giovanni, et al.
Publicado: (2022)

What do we currently know about Novichoks? The state of the art
por: Noga, Maciej, et al.
Publicado: (2022)

Preterm birth and exercise capacity: what do we currently know?
por: O’Dea, Christopher A., et al.
Publicado: (2023)

Thymic neuroendocrine neoplasms—what we know, what we don’t know, and what to do about it
por: Lang, Matthias, et al.
Publicado: (2023)

Role of the Eye in Transmitting Human Coronavirus: What We Know and What We Do Not Know
por: Sun, Chuan-bin, et al.
Publicado: (2020)

The Catecholaldehyde Hypothesis for the Pathogenesis of Catecholaminergic Neurodegeneration: What We Know and What We Do Not Know
por: Goldstein, David S.
Publicado: (2021)

Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

The risk of viral transmission in feed: What do we know, what do we do?
por: Dee, Scott A., et al.
Publicado: (2020)

Experimental subjects do not know what we think they know
por: Field, Jared M., et al.
Publicado: (2020)

Health Statistics in Australia: What We Know and Do Not Know
por: Madden, Richard, et al.
Publicado: (2022)

Equine Crofton Weed (Ageratina spp.) Pneumotoxicity: What Do We Know and What Do We Need to Know?
por: Shapter, Frances Marie, et al.
Publicado: (2023)

What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021
por: Yoo, Jin-Hong
Publicado: (2021)

The cancer-obesity connection: what do we know and what can we do?
por: Riboli, Elio
Publicado: (2014)

Isolated Nocturnal Hypertension: What Do We Know and What Can We Do?
por: Tadic, Marijana, et al.
Publicado: (2020)

Multinational monkeypox outbreak: what do we know and what should we do?
por: Memariani, Mojtaba, et al.
Publicado: (2022)

Sodium and brain injury: do we know what we are doing?
por: Zygun, David A
Publicado: (2009)

Ten years of anti-HPV vaccinations: what do we know?
por: Jach, Robert, et al.
Publicado: (2016)

COVID-19 and cancer: do we really know what we think we know?
por: Robinson, Andrew G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q1jtk7847ha15bod9e30lipkfv